<DOC>
	<DOC>NCT00443053</DOC>
	<brief_summary>To evaluate fondaparinux 2.5mg subcutaneously once daily for 45 days in the treatment of acute (recent) superficial thrombophlebitis.</brief_summary>
	<brief_title>Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis)</brief_title>
	<detailed_description>Comparison of ARIXTRA™ in lower LImb Superficial Thrombophlebitis with placebo (CALISTO). An International, Multicentre, Randomised, Double-blind, Placebo-controlled, Two-parallel Group, Phase III Study to Evaluate the Efficacy and Safety of ARIXTRA (2.5 mg subcutaneously) for the Treatment of Patients with Acute Symptomatic Isolated Superficial Thrombophlebitis of the Lower Limbs to prevent Thromboembolic Complications</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Thrombophlebitis</mesh_term>
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Inclusion criteria: Acute symptomatic superficial thrombophlebitis of the lower limbs at least 5 cm long diagnosed by compression ultrasound. Exclusion criteria: Superficial thrombophlebitis that is within 3 cm from the saphenofemoral junction, deep vein thrombosis on ultrasound exam, deep vein thrombosis or pulmonary embolism within last 6 months, treatment for cancer during last 6 months, anticoagulant medication for more than 48 hours prior to inclusion, need for oral nonsteroidal antiinflammatory drugs during the study, significant bleeding event during past month, major surgery within last 3 months, low platelet count (below 100×109/L), kidney disease (Calculated creatinine clearance &lt; 30 mL/min), woman of childbearing potential not using reliable contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>superficial vein thrombosis</keyword>
	<keyword>superficial thrombophlebitis</keyword>
	<keyword>fondaparinux</keyword>
	<keyword>deep vein thrombosis</keyword>
	<keyword>venous thromboembolism treatment</keyword>
	<keyword>thrombosis</keyword>
</DOC>